CDK
CDK (Cyclin-Dependent Kinase) inhibitors are compounds that block the activity of CDKs, a group of protein kinases that regulate the cell cycle, transcription, and other cellular processes. CDKs are activated by binding to cyclins, and their activity is crucial for the progression of cells through different phases of the cell cycle. Inhibiting CDKs can halt cell division, leading to cell cycle arrest and apoptosis, particularly in cancer cells where CDKs are often dysregulated. CDK inhibitors are widely used in cancer research and have therapeutic potential in treating various cancers. At CymitQuimica, we provide a comprehensive selection of high-quality CDK inhibitors to support your research in cell cycle control, cancer, and therapeutic development.
Products of "CDK"
Sort by
Butyrolactone I
CAS:Butyrolactone I (Olomoucin) inhibits CDKs, blocks cdc2 kinases, and shows antitumor activity in lung and prostate cancers.Formula:C24H24O7Purity:98%Color and Shape:SolidMolecular weight:424.44BRD6989
CAS:BRD6989, a cortistatin A analog, inhibits CDK8/19, enhances IL-10, and binds CDK8 with a 200 nM IC50.Formula:C16H16N4Purity:99.43%Color and Shape:SolidMolecular weight:264.33CDK4/6-IN-17
CAS:CDK4/6-IN-17 (compound 12) is an orally bioavailable inhibitor of CDK4/6, demonstrating potent activity with IC50 values between 10-100 nM in BE(2) cells.Formula:C27H28F4N8Purity:98%Color and Shape:SolidMolecular weight:540.56CDK9-IN-24
CDK9-IN-24 (compound 21a) is a potent and selective inhibitor of CDK9 that exhibits a pronounced inhibitory impact on tumor proliferation.Formula:C27H31N3O4Purity:98%Color and Shape:SolidMolecular weight:461.55CDK9-IN-28
PROTAC CDK9/CycT1 Degrader-1 (compounds 10), a potent CDK9 inhibitor, serves as a target protein ligand for PROTAC synthesis.Formula:C32H40N4O6S2Purity:98%Color and Shape:SolidMolecular weight:640.81CDK9-IN-9
CAS:CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM).Formula:C22H23F2N5O2SPurity:98%Color and Shape:SolidMolecular weight:459.51(R)-Enitociclib
CAS:(R)-Enitociclib, an enantiomer of BAY-1251152, is a CDK9 inhibitor with anticancer activity.Formula:C19H18F2N4O2SPurity:98.82%Color and Shape:SoildMolecular weight:404.43Cdc7-IN-1
CAS:Cdc7-IN-1: selective ATP-competitive Cdc7 kinase inhibitor; IC50 0.6 nM at 1mM ATP; induces cancer cell death.Formula:C21H16ClN3O4Color and Shape:SolidMolecular weight:409.82Desmethylglycitein
CAS:Desmethylglycitein (6,7,4'-Trihydroxyisoflavone) , is a novel inhibitor of PKCα in suppressing solar UV-induced matrix metalloproteinase 1, which hasFormula:C15H10O5Purity:97.93%Color and Shape:SolidMolecular weight:270.24Ref: TM-TN1299
1mg178.00€5mg540.00€10mg715.00€25mg1,103.00€50mg1,491.00€100mg2,005.00€500mg4,010.00€1mL*10mM (DMSO)442.00€Leucettinib-92
CAS:Leucettinib-92 (compound 92) is a kinase inhibitor selective for DYRK/CLK families, displaying IC50 values of 147 nM (CLK1), 39 nM (CLK2), 5.2 nM (CLK4), 0.8 μMFormula:C21H22N4OSPurity:98%Color and Shape:SolidMolecular weight:378.49SGC-CLK-1
CAS:SGC-CLK-1 is a potent and selective inhibitor of Cdc2-like kinases CLK1, CLK2, and CLK4. It effectively inhibits the growth of melanoma and glioblastoma cells.Formula:C19H15F3N6O2Color and Shape:SolidMolecular weight:416.36CDK5-IN-3
CAS:CDK5-IN-3 is a selective and potent CDK5 inhibitor that inhibits CDK5/p25 and CDK2/CycA, and can be used in the study of cancer.Formula:C22H26N4OPurity:98.21%Color and Shape:SolidMolecular weight:362.47CK7
CAS:CK7, a Cdk2/9 inhibitor, is instrumental in the synthesis of Nek1 inhibitors BSc5231 and BSc5367.Formula:C14H12N6O2SPurity:98.07%Color and Shape:SolidMolecular weight:328.35Ref: TM-T9615
1mg52.00€5mg120.00€10mg187.00€25mg376.00€50mg588.00€100mg905.00€200mg1,216.00€1mL*10mM (DMSO)139.00€Simurosertib
CAS:Simurosertib (TAK-931) is a selective and ATP-competitive cell division cycle 7 kinase inhibitor (IC50: <0.3 nM).Formula:C17H19N5OSPurity:99.82% - 99.93%Color and Shape:SolidMolecular weight:341.43Ref: TM-T12642L
1mg74.00€2mg96.00€5mg180.00€10mg250.00€25mg465.00€50mg677.00€100mg938.00€1mL*10mM (DMSO)187.00€Longdaysin
CAS:Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).Formula:C16H16F3N5Purity:99.97%Color and Shape:SolidMolecular weight:335.33Cdc7-IN-7
CAS:Cdc7-IN-7 is a potent inhibitor of Cdc7 kinase.Formula:C21H22N4O5Purity:99.25%Color and Shape:SolidMolecular weight:410.42Senexin B
CAS:Senexin B is a potent and selective inhibitor of CDK8/19(CDK8 and CDK19 with Kds of 140 nM and 80 nM).Formula:C27H26N6OPurity:99.67%Color and Shape:SolidMolecular weight:450.53Ref: TM-T8430
1mg97.00€2mg131.00€5mg188.00€10mg305.00€25mg487.00€50mg655.00€100mg905.00€1mL*10mM (DMSO)215.00€CCT-251921
CAS:CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50: 2.3 nM).Formula:C21H23ClN6OPurity:97.74%Color and Shape:SolidMolecular weight:410.9Ref: TM-T14901
1mg95.00€5mg221.00€10mg324.00€25mg548.00€50mg785.00€100mg1,074.00€1mL*10mM (DMSO)202.00€PROTAC CDK9/CycT1 Degrader-2
PROTAC CDK9/CycT1 Degrader-2 inhibits CDK9 with an IC50 of 45 nM [1].Formula:C30H36N4O6S2Purity:98%Color and Shape:SolidMolecular weight:612.76ZCL278
CAS:ZCL278 is a selective Cdc42 GTPase inhibitor.Formula:C21H19BrClN5O4S2Purity:96.29% - 99.72%Color and Shape:SolidMolecular weight:584.89Ref: TM-T1855
5mg50.00€10mg79.00€25mg136.00€50mg221.00€100mg310.00€200mg497.00€500mg805.00€1mL*10mM (DMSO)79.00€
